Is Megalencephaly Capillary Malformation Polymicrogyria Syndrome (mcap) hereditary?

Megalencephaly Capillary Malformation Polymicrogyria Syndrome (MCAP) is a genetic condition, but it is typically not hereditary, meaning it is rarely passed down from parents to children. In the vast majority of cases, Megalencephaly Capillary Malformation Polymicrogyria Syndrome is caused by a sporadic, de novo (new) mutation that occurs after conception.

Is Megalencephaly Capillary Malformation Polymicrogyria Syndrome hereditary?

While Megalencephaly Capillary Malformation Polymicrogyria Syndrome is a genetic disorder, it is almost never inherited from parents. The condition is caused by somatic mosaic mutations in the PIK3CA gene. "Somatic" means the mutation occurs in the body's cells after fertilization, rather than being present in the egg or sperm. Consequently, parents of a child with Megalencephaly Capillary Malformation Polymicrogyria Syndrome are typically not carriers, and the recurrence risk for future siblings is considered very low.

How does the genetic mutation occur in MCAP?

The genetic architecture of Megalencephaly Capillary Malformation Polymicrogyria Syndrome involves post-zygotic mutations. This means the PIK3CA mutation is present in only some of the body's cells—a state known as mosaicism. Because the mutation is not found in the germline (reproductive cells), it is not passed on through traditional Mendelian inheritance patterns like autosomal dominant or recessive traits.

What is the role of genetic testing and counseling?

Genetic testing for Megalencephaly Capillary Malformation Polymicrogyria Syndrome is highly recommended to confirm the diagnosis and distinguish it from other overgrowth syndromes. Testing is usually performed via:

• Targeted PIK3CA gene sequencing from affected tissue (such as skin biopsies from capillary malformations).


• Deep sequencing of blood samples, though mosaic mutations may sometimes be missed in blood due to low-level expression.


• Clinical genetic counseling to help families understand the sporadic nature of the condition and the low recurrence risk for future pregnancies.

Are there prenatal diagnosis options?

Because Megalencephaly Capillary Malformation Polymicrogyria Syndrome is rarely inherited, routine prenatal screening for parents who have already had an affected child is generally not indicated. However, if a parent is found to have germline mosaicism—an extremely rare occurrence—prenatal diagnosis via amniocentesis or chorionic villus sampling could be discussed with a genetic counselor.

Next steps

• Consult with a clinical geneticist to discuss molecular testing options for Megalencephaly Capillary Malformation Polymicrogyria Syndrome.


• Join the DiseaseMaps.org community to connect with other families navigating this diagnosis.


• Request a referral to a specialist center familiar with PIK3CA-related overgrowth spectrum (PROS) disorders.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Rare Disease Database (ORPHA:254760)


• Online Mendelian Inheritance in Man (OMIM #602501)


• PIK3CA-Related Overgrowth Spectrum (PROS) clinical literature on PubMed